Meet Luke O’Pak the Leukopak Bag. Join him by visiting https://t.co/MWqPpa8QPi to see how you can help make a difference. Get Luke’s coloring page. https://t.co/5GQaHMfSVX #TerumoBCT #Leukopaks #Leukapheresis

We’re proud to have won the People’s Choice Award at this year’s #Canstruction — thanks to the incredible volunteers who turned 5,500 cans into a powerful display of hope. Every can is being donated to @TheActionCenter to help families in need. 💙

Terumo Blood and Cell Technologies is joining the #WaveOfGenerosity for #ColoradoGivesDay! Every act of giving creates a wave of impact. Thanks @ColoradoGivesFoundation for inspiring us to support local nonprofits!

✨ After 10 hours, 5,500+ cans, and one incredible team … it’s finally here! From the Denver skyline to the mountain peaks, our #Canstruction design celebrates community and the life-giving power of blood. Vote Terumo BCT in the People’s Choice Award! https://t.co/jEQjPIuO39

We’re honored to receive the Making Good Happen Impact Award at the 2025 Jeffco EDC Gateways Awards! At Terumo BCT, giving back is who we are. #TerumoProud @jeffcoedc

https://t.co/xL8mtKssJW

https://t.co/BqY9x15Ohq

Over the next 12 hours, 28 of our associates will build a structure made entirely of canned food — all donated to The Action Center❤️ #Canstruction2025 ➡️ Check the comments to meet part of the team!

✨ Welcome to the #SeasonofHope ✨ As the year winds down, we reflect on why we do what we do—to give more time and more hope. Join us as we share the stories and science that bring our purpose to life. #UnlockingPotential #TerumoBCT #PatientImpact

📲 “Vivienne! Lost you for a sec — but I’ve got more to show you …” Sheila’s back and touring the globe 🌍: China, Australia, Japan, Brazil, India & the U.S. Because no matter the language, we train together — for better care. #BetterTogether #TerumoBCTAroundTheWorld

📲 “Sheila, are you there? Wait — now I hear you!” Peek into Vivienne Wint’s call with Sheila Doshi to see how our teams train together across EMEA borders to support better care for patients. #BetterTogether #AroundTheWorld

The winner of the People’s Choice Award presented by @SouthwestAir is…the Spectra Optia Apheresis System by @terumobct! Congratulations on being the People’s Choice winner! #CoolestThingMadeC

Spectra Optia wins the 2025 People’s Choice Award! Your votes made it happen — thank you for helping us with this recognition. #CoolestThingMadeInColorado #MedTech @ColoradoChamber

Plasma saves lives—and it takes all of us to make it possible. This Plasma Awareness Week, we thank donors worldwide for showing us we’re always #BetterTogether. Learn more https://t.co/mQHEYRL8Ax #PlasmaPowersPossibility #IPAW2025

⏳ Final countdown! Voting for the Coolest Thing Made in Colorado People’s Choice Award ends soon. Don’t forget to vote for Spectra Optia — Colorado-made innovation with global impact. 🗳️ Vote now: https://t.co/C9BIOJHrS0 #CoolestThingMadeInColorado #SpectraOptia

🏭 Happy #MFGDay25 from Lakewood, CO! We’re proud to build the Spectra Optia Apheresis System — trusted worldwide, and now a finalist for the Coolest Thing Made in Colorado! 🗳️ Vote by Oct 6: https://t.co/C9BIOJHrS0 #CoolestThingMadeInColorado #SpectraOptia @ColoradoChamber

We are proud to share the signing of three new Memoranda of Understandings with the Ministries of Health in Kenya and Côte d’Ivoire and with Uganda’s Joint Clinical Research Centre. Read more in our press release: https://t.co/jx2dEc0cvJ #SickleCellDisease #SCD #GlobalHealth

Behind every innovation are the people who make it possible. 💡 From Colorado to the world, the Spectra Optia Apheresis System is changing lives—and it’s a finalist for the Coolest Thing Made in Colorado. 📷 Vote today: https://t.co/C9BIOJHZHy

🌍✨Boa notícia no #DiaMundialDaAférese: O Spectra Optia recebeu aprovações em 14 países da América Latina — ampliando o acesso a terapias para doença falciforme, síndrome de Guillain-Barré e miastenia gravis. Saiba mais: https://t.co/AoAY8mdTzF #DoençasRaras #AcessoDoPaciente

🌍✨Buenas noticias en el #DíaMundialDeLaAféresis: Spectra Optia obtuvo aprobaciones en 14 países de América Latina — ampliando el acceso a terapias para enfermedad de células falciformes, síndrome de Guillain-Barré y miastenia gravis. Más info: https://t.co/zswqjn7kZF